ZA989665B - The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes. - Google Patents

The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes.

Info

Publication number
ZA989665B
ZA989665B ZA9809665A ZA989665A ZA989665B ZA 989665 B ZA989665 B ZA 989665B ZA 9809665 A ZA9809665 A ZA 9809665A ZA 989665 A ZA989665 A ZA 989665A ZA 989665 B ZA989665 B ZA 989665B
Authority
ZA
South Africa
Prior art keywords
glycosaminoglycans
diabetes
pharmaceutical preparations
disorders associated
eye disorders
Prior art date
Application number
ZA9809665A
Other languages
English (en)
Inventor
F J Van Der Woude
Dieter Herr Volker Laux
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of ZA989665B publication Critical patent/ZA989665B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA9809665A 1997-10-24 1998-10-23 The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes. ZA989665B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19747195A DE19747195A1 (de) 1997-10-24 1997-10-24 Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten

Publications (1)

Publication Number Publication Date
ZA989665B true ZA989665B (en) 2000-04-25

Family

ID=7846613

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9809665A ZA989665B (en) 1997-10-24 1998-10-23 The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes.

Country Status (13)

Country Link
EP (1) EP1047434A2 (xx)
JP (1) JP2001520987A (xx)
KR (1) KR20010024550A (xx)
CN (1) CN1277554A (xx)
AU (1) AU749673B2 (xx)
BR (1) BR9813098A (xx)
CA (1) CA2306379A1 (xx)
DE (1) DE19747195A1 (xx)
HU (1) HUP0004647A3 (xx)
IL (1) IL135171A0 (xx)
NO (1) NO20001895L (xx)
WO (1) WO1999021538A2 (xx)
ZA (1) ZA989665B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
CN101584704B (zh) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 肝素、低分子肝素可药用盐或其衍生物的医药用途
WO2011122321A1 (ja) * 2010-03-29 2011-10-06 国立大学法人名古屋大学 ヘパリン結合性蛋白に対する生理活性阻害剤
CN107137421A (zh) * 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597484B1 (fr) * 1986-04-17 1988-12-23 Sanofi Sa Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
DE3875349D1 (de) * 1988-06-27 1992-11-19 Roland Reiner Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
WO1995005182A1 (en) * 1993-08-13 1995-02-23 Glycomed Incorporated Bridged oligosaccharides and sulfated derivatives thereof
EP0722326A4 (en) * 1993-10-07 1999-10-06 Glycomed Inc HIGHLY SULFATED MALTOOLIGOSSACCHARIDES WITH HEPARIN-LIKE PROPERTIES
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
WO1999004801A1 (en) * 1997-07-28 1999-02-04 Rijks Universiteit Leiden Use of sulfated glycosaminoglycans for treating of retinopathy

Also Published As

Publication number Publication date
NO20001895D0 (no) 2000-04-12
NO20001895L (no) 2000-04-12
DE19747195A1 (de) 1999-04-29
AU749673B2 (en) 2002-07-04
EP1047434A2 (de) 2000-11-02
CN1277554A (zh) 2000-12-20
IL135171A0 (en) 2001-05-20
KR20010024550A (ko) 2001-03-26
JP2001520987A (ja) 2001-11-06
CA2306379A1 (en) 1999-05-06
BR9813098A (pt) 2000-08-15
HUP0004647A2 (hu) 2001-05-28
WO1999021538A3 (de) 1999-08-05
AU1335599A (en) 1999-05-17
HUP0004647A3 (en) 2002-01-28
WO1999021538A2 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
HUP9800467A3 (en) Use of hyaluronic acid for producing pharmaceutical compns. for the treatment of interstitial cystitis
EP0658111A4 (en) METHODS FOR FACILITATING THE DELIVERY OF MEDICAMENTS USING MODIFIED SAPONINS.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
IL148870A0 (en) 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
ZA97976B (en) Uniform drug delivery theraphy.
AU2508597A (en) Drug for the treatment of tumours
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
EP0601909A3 (en) Dibekacin derivatives and arbekacin derivatives active against resistant bacteria, and the production thereof.
HUP9601305A2 (en) Fluorine-containing benzoyl-guanidine derivatives, pharmaceutical compns. contg. them, process for preparing the said compds. and the use of the compds.
HUP9600665A3 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
ZA989665B (en) The use of glycosaminoglycans for producing pharmaceutical preparations for treating eye disorders associated with diabetes.
HK1038510A1 (en) Use of neurotrophic factor stimulators for the treamtent of ophthalmic neurodegenerative diseases.
MXPA01003761A (es) Agente para tratar oftalmopatia.
EP0968716A4 (en) MEDICINES FOR THE TREATMENT OF EYE CIRCULATORY DISORDERS
HUP9904181A3 (en) Sufrace-stabilised pharmaceutical preparation for application on the skin
ZA932450B (en) Drugs for the treatment of diabetes
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
ZA93694B (en) Pharmaceutical treatments.
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
HUT76806A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents
GR1002048B (en) Phenilacetic acid derivatives, process for the preparation thereof and corresponding use.